NeuroPace, Inc.

Healthcare

NASDAQ:NPCE · NASDAQ Global Market

Market Cap $532.89M Beta 1.88 P/E (TTM) -23.8

$15.63 +0.30%

+$0.05 today

52W Low $7.56High $19.60

Vol 0.13M · Avg 0.18M

EPS (TTM) -$0.64Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+47.87%

Period High

$19.29

Period Low

$8.25

Latest

$15.63

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

BrainsWay Ltd.

NASDAQ:BWAY

$567.07M

Cerus Corporation

NASDAQ:CERS

$529.98M

Delcath Systems, Inc.

NASDAQ:DCTH

$404.77M

908 Devices Inc.

NASDAQ:MASS

$329.54M

Sight Sciences, Inc.

NASDAQ:SGHT

$280.48M

Senseonics Holdings, Inc.

NASDAQ:SENS

$272.08M

RxSight, Inc.

NASDAQ:RXST

$194.77M

CVRx, Inc.

NASDAQ:CVRX

$130.29M

Aldeyra Therapeutics, Inc.

NASDAQ:ALDX

$116.72M

Genelux Corporation

NASDAQ:GNLX

$108.34M

What is the latest NPCE filing?

The latest filing shown is 8-K dated Jun 8, 2026.

How many recent filings does NPCE have?

Intrinsic Alpha currently shows 20 recent filings for NPCE.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.